These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9512873)

  • 1. A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation.
    Qayumi KA; English JC; Feeley EJ; Poostizadeh A; Nikbakht-Sangari M
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):777-85. PubMed ID: 9512873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1.
    Qayumi AK; English JE; Duncan S; Ansley DM; Pearson B; Nikbakht-Sangari M; Sammartino C; Fradet G
    J Heart Lung Transplant; 1997 Sep; 16(9):946-55. PubMed ID: 9322146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor administration of PAF antagonist (TCV-309) enhances lung preservation.
    Ide S; Kawahara K; Takahashi T; Sasaki N; Shingu H; Nagayasu T; Yamamoto S; Tagawa T; Tomita M
    Transplant Proc; 1995 Feb; 27(1):570-3. PubMed ID: 7879103
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation.
    Qayumi AK; Jamieson WR; Poostizadeh A
    Ann Thorac Surg; 1991 Oct; 52(4):1026-32. PubMed ID: 1929620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
    Stammberger U; Carboni GL; Hillinger S; Schneiter D; Weder W; Schmid RA
    J Heart Lung Transplant; 1999 Sep; 18(9):862-8. PubMed ID: 10528748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation.
    Takada Y; Boudjema K; Jaeck D; Bel-Haouari M; Doghmi M; Chenard MP; Wolf P; Cinqualbre J
    Transplantation; 1995 Jan; 59(1):10-6. PubMed ID: 7839408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of red cell antioxidant status and heart-lung function in swine pretreated with allopurinol (a model of heart-lung transplantation).
    Qayumi AK; Godin DV; Jamieson WR; Ko KM; Poostizadeh A
    Transplantation; 1993 Jul; 56(1):37-43. PubMed ID: 8333065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation.
    Hirt SW; Wahlers T; Jurmann M; Dammenhayn L; Rohde R; Haverich A
    Transpl Int; 1992; 5 Suppl 1():S374-8. PubMed ID: 14621825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
    Corcoran PC; Wang Y; Katz NM; Rajan SS; Analouei AR; Foegh ML; Wallace RB
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):66-72. PubMed ID: 1614217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term lung preservation with the PAF antagonist BN 52021.
    Conte JV; Katz NM; Wallace RB; Foegh ML
    Transplantation; 1991 Jun; 51(6):1152-6. PubMed ID: 2048190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating factor antagonist enhances lung preservation.
    Corcoran PC; Wang Y; Katz NM; St Louis JD; Foegh ML; Rajan SS; Analouei AR; Wallace RB
    J Surg Res; 1992 Jun; 52(6):615-20. PubMed ID: 1528038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of a PAF antagonist against liver injury induced by warm ischemia or cold preservation.
    Wang KS; Monden M; Kanai T; Umeshita K; Ukei T; Nakano H; Gotoh M; Mori T
    Transplant Proc; 1992 Aug; 24(4):1596-8. PubMed ID: 1496669
    [No Abstract]   [Full Text] [Related]  

  • 13. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.
    Yin M; Buurman WA; Daemen JW; Kootstra G
    Transplantation; 1996 May; 61(10):1443-6. PubMed ID: 8633367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to allopurinol pretreatment in a swine model of heart-lung transplantation.
    Qayumi AK; Jamieson WR; Godin DV; Lam S; Ko KM; Germann E; Van den Broek J
    J Invest Surg; 1990; 3(4):331-40. PubMed ID: 2291890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury.
    Nikbakht-Sangari M; Qayumi AK; Keown PA
    Immunol Invest; 2000 Feb; 29(1):13-26. PubMed ID: 10709843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation.
    Takada Y; Taniguchi H; Fukunaga K; Yuzawa K; Otsuka M; Todoroki T; Iijima T; Fukao K
    Surgery; 1998 Jun; 123(6):692-8. PubMed ID: 9626320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats.
    Wang KS; Monden M; Kanai T; Gotoh M; Umeshita K; Ukei T; Mori T
    Surgery; 1993 Jan; 113(1):76-83. PubMed ID: 8417492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of inhaled nitric oxide, gabexate mesilate, and retrograde flush in the lung graft from non-heart beating minipig donors.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    Transplantation; 2000 May; 69(10):2019-27. PubMed ID: 10852590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion.
    Yoshikawa T; Takahashi S; Naito Y; Ueda S; Tanigawa T; Yoshida N; Kondo M
    Lipids; 1992 Dec; 27(12):1058-60. PubMed ID: 1487954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.